Chinas health authorities have said the Covid-19 wave is past its peak, with rapid decline in both severe cases and deaths in hospitals, but experts remain wary of the governments official data
Macleods Pharmaceuticals is recalling around 10,000 bottles of generic antibiotic medication in the US market due to a labelling error, according to the US health regulator. As per the latest enforcement report by the US Food and Drug Administration (USFDA), Macleods Pharma Inc, a US-based unit of the company, is recalling 10,052 bottles of Levofloxacin tablets, which are used to treat different types of bacterial infections. The company is recalling the affected lot due to"mismatching of the embossing on the tablets with the embossing mentioned in the package insert in the distributed bottles." Macleods manufactured the affected lot in its Baddi-based manufacturing plant in Himachal Pradesh. The company initiated the Class III recall in the US and Puerto Rico on January 5. As per the USFDA, a Class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. The US generic drug market was estimate
Covid has highlighted the need for adequate infrastructure and health care workforce, especially doctors and nurses
Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022. The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal. Revenue from operations rose to Rs 6,770 crore during the period under review as against Rs 5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.
Just as the ECG sensor on your health app uses electrical sensors on the back of the wearable wristband to measure heart health, EEG sensors embedded in ear buds can measure brain health
Hospitals are expected to report a soft Q3 result due to a mix of seasonality and easing pent-up demand, however, average revenue per occupied bed is likely to remain steady
MoS Health said that emergency preparedness was no longer an initiative in isolation, but rather "an overarching priority" which "requires efforts to build resilient health systems
Stocks to Watch: Infosys and HCL Technologies to announce Q3 results; Sah Polymers to debut on Thursday.
State govt tells revellers to end New Year celebrations before 1 am; Centre readies for mock drills today
The airport tests are aimed at a 2 per cent sample of all incoming international travellers
Less than 30,000 booster doses daily in December, vaccine coverage flat for two months
Tamil Nadu health minister Ma Subramanian said incentives would be provided to all those who work for the Makkalai Thedi Maruthuvam scheme
Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US.
Hello Logistics Inc., which operates under the name NextMed, sued Mehta, his business partner Tejasvi Singh, and their company Cloud Health Systems over allegations of misappropriation of trade secret
Union Health Minister Mansukh Mandaviya on Friday said more than 1,500 private hospitals have been empanelled under the Ayushman Bharat scheme in the last one year. The scheme is reviewed every month and out-of-pocket expenditure of patients under the scheme has come down, Mandaviya said, replying to a question in Lok Sabha. Under the scheme launched in 2018, the government provides health security cover to 10 crore families or 50 crore people of India. Today, 4.5 crore needy people have been empanelled under the scheme, the minister said. He said seven-eight lakh beneficiary cards are printed daily and the ministry was working to ensure that 50 crore cards are made available in the next four-six months. "Poor and needy people are covered under the Ayushman Bharat scheme and they can avail Rs 5 lakh health security cover. Any hospital can empanel under the scheme ... In the last one year, more than 1,500 private hospitals have been empanelled under the scheme," Mandaviya said duri
'Irreparable damage' to Indian pharma's global image, drug regulator writes to WHO
The Biden administration on Wednesday proposed a ban on misleading ads for Medicare Advantage plans that have targeted older Americans and, in some cases, convinced them to sign up for plans that don't cover their doctors or prescriptions. The rule, proposed by the Centers for Medicare and Medicaid Services, would ban ads that market Medicare Advantage plans with confusing words, imagery or logos. The rule also would ban ads that don't specifically mention a health insurance plan by name. It's an aggressive step to tackle a growing problem in the Medicare Advantage marketplace, a booming business that offers privately run versions of the government's Medicare program for people who are 65 and older or have disabilities. Nearly half of all Medicare enrollees about 28 million are now turning to Medicare Advantage plans. And some have been deceived by television commercials, online ads and mailers put out by the marketing agencies and brokers that some insurers have hired to win over
At its annual event called Inno Day 2022, Chinese electronics maker announced its maiden health monitor called OHealth H1, MariSilicon Y chip, and augmented reality headset Air Glass 2
The first nine patients that they will inject would be legally blind, as they have to prove safety first
Move will mark firm's digital healthcare foray 18 months after announcement; firm also plans to enter mental and respiratory illness segments, cover 28-30 cities by CY 2023-end